Mass spectrometry in clinical proteomics - from the present to the future.
about
Developments in FTICR-MS and Its Potential for Body Fluid SignaturesAvailability of MudPIT data for classification of biological samplesMass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals.Imaging and 'omic' methods for the molecular diagnosis of cancer.Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Association between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients.Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material.Biomarker discovery and redundancy reduction towards classification using a multi-factorial MALDI-TOF MS T2DM mouse model dataset.Serum peptidome profiling in patients with gastric cancer.Precision profiling and identification of human serum peptides using Fourier transform ion cyclotron resonance mass spectrometry.Serum protein profiles as potential biomarkers for infectious disease status in pigs.Mass-spectrometry-based clinical proteomics--a review and prospective.A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder.Improved classification of breast cancer peptide and protein profiles by combining two serum workup proceduresRadiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissueLaser ionization mass spectrometry in oral squamous cell carcinoma.Advances in tissue section preparation for MALDI imaging MS.Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot studyEffects of sample delivery on analyte capture in porous bead sensors.Partial-Body Irradiation in Patients with Prostate Cancer Treated with IMRT Has Little Effect on the Composition of Serum Proteome.Clinical application of urinary proteomics/peptidomics.Proteomics for discovery of candidate colorectal cancer biomarkers.Glycans and glycoproteins as specific biomarkers for cancer.Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity.Bottom-Up Mass Spectrometry-Based Proteomics as an Investigative Analytical Tool for Discovery and Quantification of Proteins in Biological Samples.ExSTA: External Standard Addition Method for Accurate High-Throughput Quantitation in Targeted Proteomics Experiments.Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer.
P2860
Q26863208-7A135181-463D-46A0-8470-A906AB0D6D0CQ30585972-BCE9652E-5783-433E-8E31-A565D271D159Q30985472-AB4BF0C2-17E6-4759-979C-0C6FB1AD92F9Q33481276-3B0EC667-5138-476E-8383-552C506C6267Q33527649-6019A17B-EC31-428E-B6FC-CFAB22BC55CAQ33577268-6DEB837B-0ABB-4068-8478-A11AA13FD3A7Q33602325-0F78A1AD-FA12-48DB-A460-4695FBD7B4A4Q33651645-CF7F5061-7114-499C-8C17-6DD2FCA11B01Q33781011-9648B1E4-6621-4530-9D95-CFD67D90AA1AQ33829971-1525B7DB-11A4-4753-9ADD-32D8E9C304B7Q33850368-30D17A5A-B90C-42B0-9428-32253BCD4243Q33893305-FBCCF1F0-B280-4551-A6BF-8C8EE00C6434Q33955495-1D83FFE5-0AD0-4D35-AC06-0E05CF1D050FQ34077436-B3276A38-3914-46FF-9D53-83EA46C13C0FQ34206959-B339CE1A-86BB-4454-BD54-0995A8F82DD5Q34252113-9029E48A-6DCF-495E-92E6-0A3B0FE78ECAQ34267851-3496E6C4-BB2F-4A17-B1BC-3022588D57C5Q34327104-993E1435-6622-4F2E-B124-E579DB78F9FCQ34530393-F6CC66FA-97FF-4901-8F25-239AD40791DAQ35013394-D82CBA73-3085-465A-AB5C-2F9214B72016Q35164791-2519976C-CB6E-41D1-A9E6-C5E8CAA1E4FBQ35518214-E926627E-63DC-47DF-8EC1-611CB7EB6D10Q35560299-8B3B4C9A-BC67-4770-9712-D725AE40A085Q35777594-AD755B03-947F-4CBF-B85A-07805E68C85BQ36522816-24AC33F4-8226-4A44-9828-1FAD55DD7C2EQ37566459-6CB6A789-F066-431C-BAFE-D175E28D975AQ37945790-BAAF2A5F-A537-4C67-8A3B-84521737C447Q38205429-C48C7F1B-414C-4408-A4DB-D41DEEBCFF40Q38945184-99EEF920-3187-4662-9B73-1D7F79D27AAEQ39172554-0800BE5B-3418-4668-9F56-AEABCC612BDEQ42862273-542D306F-764C-4F2F-89EF-E15C27AE170FQ47818859-4EBB8BD2-26E1-473D-B003-769E16FE3FD4Q55279779-409F845E-B69A-404D-A8B1-EB87F888CE9F
P2860
Mass spectrometry in clinical proteomics - from the present to the future.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Mass spectrometry in clinical proteomics - from the present to the future.
@en
Mass spectrometry in clinical proteomics - from the present to the future.
@nl
type
label
Mass spectrometry in clinical proteomics - from the present to the future.
@en
Mass spectrometry in clinical proteomics - from the present to the future.
@nl
prefLabel
Mass spectrometry in clinical proteomics - from the present to the future.
@en
Mass spectrometry in clinical proteomics - from the present to the future.
@nl
P2860
P50
P356
P1476
Mass spectrometry in clinical proteomics - from the present to the future
@en
P2093
P2860
P356
10.1002/PRCA.200800090
P577
2008-11-20T00:00:00Z